Financing · Jul 10, 2026

Traws Pharma, Inc. filed a prospectus supplement dated July 10, 2026, to its effective shelf registration statement…

ONTXTraws Pharma, Inc.

Traws Pharma, Inc. filed a prospectus supplement dated July 10, 2026, to its effective shelf registration statement, enabling the company to offer and sell common stock with an aggregate offering price of up to $5,575,709 through its existing At The Market (ATM) offering agreement with Citizens JMP Securities, LLC. This sale is subject to ability to use its current "baby shelf